Tiff Advisory Services LLC Purchases 346,256 Shares of The Oncology Institute, Inc. (NASDAQ:TOI)

Tiff Advisory Services LLC raised its position in The Oncology Institute, Inc. (NASDAQ:TOI) by 13.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,979,141 shares of the company’s stock after buying an additional 346,256 shares during the quarter. Oncology Institute comprises about 0.3% of Tiff Advisory Services LLC’s portfolio, making the stock its 18th largest position. Tiff Advisory Services LLC owned about 3.94% of Oncology Institute worth $921,000 at the end of the most recent reporting period.

Separately, HighTower Advisors LLC boosted its stake in shares of Oncology Institute by 190.8% in the 3rd quarter. HighTower Advisors LLC now owns 81,362 shares of the company’s stock valued at $27,000 after purchasing an additional 53,382 shares in the last quarter. 36.86% of the stock is currently owned by institutional investors.

Oncology Institute Trading Down 15.0 %

TOI opened at $0.72 on Tuesday. The company’s 50 day moving average is $0.66 and its 200-day moving average is $0.41. The Oncology Institute, Inc. has a 1-year low of $0.13 and a 1-year high of $1.94. The company has a current ratio of 2.49, a quick ratio of 2.27 and a debt-to-equity ratio of 5.91. The company has a market cap of $54.70 million, a P/E ratio of -0.93 and a beta of 0.37.

Oncology Institute Company Profile

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.